Offstream
news

---

Changes

1. Nigeria approves the emergency use of Oxford–AstraZeneca vaccine produced by the Serum Institute of India.
   2021-02-19 01:05:54 (First version)
2. Nigeria approves the emergency use of the Oxford–AstraZeneca vaccine produced by the Serum Institute of India.
   (Current version)

---

Related

Nigeria destroys 1,066,214 doses of the Oxford–AstraZeneca COVID-19 vaccine with short shelf lives that expired in November.
2021-12-22

Madagascar receives its first shipment of 50,000 doses of the Covishield vaccine manufactured by the Serum Institute of India.
2021-05-8

Ethiopia receives its first shipment of 2.2 million doses of the Oxford–AstraZeneca vaccine manufactured by the Serum Institute of India supplied through the COVAX vaccine-sharing initiative.
2021-03-7

Rwanda receives its first shipment of 240,000 doses of the Oxford–AstraZeneca vaccine manufactured by the Serum Institute of India through the COVAX vaccine-sharing initiative.
2021-03-3

Nigeria receives 3.94 million doses of the Oxford–AstraZeneca vaccine manufactured by the Serum Institute of India through the COVAX Initiative, which is the largest delivery so far by the initiative.
2021-03-2

Health Canada authorizes the use of the Oxford–AstraZeneca vaccine and a related vaccine made by the Serum Institute of India.
2021-02-26

Bangladesh receives their second shipment of two million doses of the Oxford–AstraZeneca vaccine from the Serum Institute of India.
2021-02-23

Ukraine receives their first shipment of 500 doses of the Oxford–AstraZeneca vaccine manufactured by the Serum Institute of India.
2021-02-23

South Africa receives one million doses of the Oxford-AstraZeneca vaccine produced by the Serum Institute of India.
2021-02-1

Myanmar receives its first 1.5 million doses of the Oxford-AstraZeneca COVID-19 vaccine manufactured by the Serum Institute of India.
2021-01-22